Skip to content
By using this website, you consent to our use of cookies. For more information, visit our Privacy Policy
-
“It’s really hard to think about recovery, or putting down substances, when your basic human needs aren’t being met.”
-
It’s unlikely pharmaceutical executives will face a full reckoning in court, but transformative justice could give victims the relief they deserve.
-
October 2, 2017
Here’s how to get him out.
-
Could the president be influenced by threats to his profit margin?
-
The stakes are higher now than ever. Get The Nation in your inbox.
-
A trip to Cuba reminds us of the delicate nature of American politics.
-
Drone strikes, the war in Afghanistan, and America’s obsession with itself are all alive and well.
-
Every major candidate from both parties has plans to maintain some version of Washington’s drone campaigns.
-
It's time for international negotiations to finally begin.
-
Despite the uproar over reductions to defense funding, less than 1 percent of the Pentagon's beefy $550 billion budget will be cut this year.
-
Who decides what’s “essential” during a government shutdown?